Fennec Pharmaceuticals (FENC)

• Market cap: $313M
• 1 day: 1.69%
• 5 days: 0%
• 1 month: 28.02%
• 3 months: 17.96%
• 6 months: 19.21%
• Year to date: 17.19%
• 1 year: 8.17%
• 5 years: 34.53%
• 10 years: -25%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 35